key: cord-0325187-xezkimof authors: Kumar, S.; Lomash, A.; Faruq, M.; Siddiqui, O.; v, S.; Suravajhala, P.; Polipalli, S. K.; LNH, SCOGMAMC title: Amplicon-based nanopore minion sequencing of patients with COVID-19 omicron variant from India date: 2021-12-30 journal: nan DOI: 10.1101/2021.12.27.21268364 sha: dc434b89f5766c2a3524419af81cb75488bde806 doc_id: 325187 cord_uid: xezkimof SARS-CoV-2 infection has been playing havoc with emerging omicron variants of concern (VoC). Here, we report sequencing of the omicron variant in 13 patients from India using Oxford Nanopore Technology (ONT) Minion, wherein a rapid amplicon based sequence analysis was performed to assess and compare with existing 34 mutations in spike glycoprotein. We highlight and discuss the nature of these mutations that are unique and common to other populations. This is perhaps the first report on omicron variants from India using a long read sequencing chemistry. Coronavirus Disease (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and has been an unfolding saga as the most discussed disease in recent times (www.who.int last is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint also seen 213 omicron cases with 4,79,000 deaths and over 29.8 million recovered so far (as on December 23, 2021). Early signs from previous reports indicate that omicron causes mild symptoms and the incidental findings would allow us to discern the modality behind emerging variants from India. Understanding the omicron variants would also help facilitate better prophylaxis on comorbidities with clinical presentations thereby distinguishing patterns associated with infection. Patients' samples: The nasopharyngeal swab samples were collected from 13 patients who have had a travel history of Africa/Middle-East. The patients were presented with mild symptoms within three days of onset of infection prior to hospitalization. Informed consent was judiciously taken before the sample was sequenced. The nucleic acid from these cases were subjected to Oxford Nanopore Technologies (ONT) long-read whole genome sequencing by preparing libraries using the midnight protocol of ARTIC classic approach (Catalog id SQL-RBK-110-96). The approach entails a series of short steps by sequencing and simultaneously mapping the reads to the reference genome besides analyzing the output data in real time (https://nanoporetech.com/covid-19; assessed December 14, 2021). The rapid 5-hour workflow, with 15min fast library preparation was applied for backward tracing of the strains out of the lab, bringing genomic/molecular epidemiology analysis for discovery of mutations. Using the PCR tiling approach, the viral genome was amplified in overlapping sections across the full length of the genome with the Minion flow cell (FLO/106), following which base calling was performed; reads mapped and filtered to the Wuhan reference genome. The samples were labeled with in house registry identities and further named as LNHD1, LNHD2 and so on. Data pipeline and phylogenetic analysis: After the library preparation was done, careful execution of bar codes were supplied with the samples which were later run through MinKnow for approximately 3 hours so as to obtain fast5 files. The fast5 files were converted to fastq and a final annotation report was obtained through a series of steps. Commander was used to streamline the report as the workflow ensured all barcodes were run through quality check, amplicon coverage, genome coverage, variant calling and VCF file generation (https://genotypic.co.in/Commander; last accessed December 23, 2021). A 20x mean coverage of ca. 96.28% raw reads were mapped to SARS-CoV-2 reference genomes (accessions MN908947.3/NC_0145512), and a few sequences indicative of variable coverage ('N' or 'X'). Using the initial set of these sequences, we have taken ''good-sequence'' alignment of all 13 omicron cases from India aligned to Wuhan reference, and a neighborhood joining tree was constructed using clustal omega with the sequences sorted vertically, thereby drawing a circular and unrooted tree (Sievers is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted December 30, 2021. ; https://doi.org/10.1101/2021.12.27.21268364 doi: medRxiv preprint et al. 2021). Finally, the GIASIA's audacity instance was used to identify the mutations in spike glycoprotein and calculate the neighbor distance between related sequences, and datawrapper (datawrapper.de last accessed December 23, 2021) was used to plot the sequence data. All the 13 sequences were uploaded to the Global Initiative for Sharing All Influenza Data (GISAID) (Elbe and Buckland-Merrett, 2017) submission making data available for free access. The ONT minion yielded a total read length attributing to 25 million reads on an average from all 13 samples, and the genomic GC content varied from ca. 40 to 43% covering 96.28% of the SARS-CoV-2 genome (20x) (Table 1; Figure 1a is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted December 30, 2021. ; https://doi.org/10.1101/2021.12.27.21268364 doi: medRxiv preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint showed that the mutational load or overburden could be attributed from delta or previous lineages ( BA. 1; Supplementary Table 5) The outbreak of COVID-19 caused by SARS-CoV-2 has swiftly spread worldwide with the probable origin of omicron still unclear. Interestingly, all the emerging case reports with no or mild upper respiratory tract symptoms are either with asymptomatic or oligosymptomatic transmission (Kupferschmidt K and Vogel G, 2021) . The limitation of our study is that although the adopted ARCTIC protocol allowed the confirmation of SARS-CoV-2 infections, given the urgent need for rapid identification and traceability of omicron variants, an indefatigable checking the antibody titer against deleterious mutations and subsequent single cell genomic assay would have been a better proposition (Kannan et al. 2022). Furthermore, the difference in viral loads among samples will possibly affect the stability of average depth and genomewide coverage with increase in whole-genome mapping. In summary, our study has demonstrated the utility of nanopore sequencing for SARS-CoV-2 genomes from clinical specimens. We firmly hope that prompt diagnosis and rapid whole-genome analysis would allow a decisive response to the SARS-CoV-2 outbreak that will bring disease control and prevention efforts. SKu and SKa co-led the investigation and surveillance of the project., SK, SKP and PS wrote the draft and proofread the manuscript before all authors agreeing to the final version Medical Director, LNH and Head of Department of Medicine Director Professor, Department of Pediatrics, Maulana Azad Medical College Director Professor & Head of Department, Department of Microbiology, Maulana Azad Medical College Director Professor and Head, Department of Biochemistry and Chairman Director Professor Dr Vikas Manchanda, Professor, Department of Microbiology, Maulana Azad Medical College 11. Dr. Rajesh Pandey, Senior Scientist, CSIR IGIB CC-BY-NC 4posted Additional Director, NCDC, New Delhi 16. Dr. Arvind Mohan, Medical Officer, Department of Medicine, Maulana Azad Medical College, New Delhi 17. Dr. Meenakshi Bothra, Assistant Professor, Department of Pediatrics Thalassemia Screening programme, Lok Nayak Hospital International risk of SARS-CoV-2 omicron variant importations originating in South Africa Data, disease and diplomacy: GISAID's innovative contribution to global health Interactive Tree Of Life (iTOL) v5: an online tool for phylogenetic tree display and annotation The Omic Insights on Unfolding Saga of COVID-19. Front Immunol Omicron SARS-CoV-2 variant: Unique features and their impact on pre-existing antibodies How bad is omicron? Some clues are emerging mCSM: predicting the effects of mutations in proteins using graph-based signatures is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprintThe copyright holder for this this version posted December 30, 2021. ; https://doi.org/10.1101/2021.12.27.21268364 doi: medRxiv preprint It is made available under a perpetuity.is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprintThe copyright holder for this this version posted December 30, 2021. ; https://doi.org/10.1101/2021.12.27.21268364 doi: medRxiv preprint